An in-depth look to ORIENT EUROPHARMA CO operating, investing, and financing activities

4120 free cash flow for Q3 24 is 48.96 M TWD. For 2023, 4120 free cash flow was 23.6 M TWD and operating cash flow was 123 M TWD.